Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Johan W. Molling"'
Autor:
Renée C.G. de Bruin, Johannes A. Langendijk, Rik J. Scheper, C. René Leemans, Tanja D. de Gruijl, Hans van Vliet, Henk M.W. Verheul, Johan W. Molling, Ruud H. Brakenhoff, Alfons J.M. van den Eertwegh, Famke L. Schneiders
Publikováno v:
Journal of Clinical Oncology, 30(5), 567-570. American Society of Clinical Oncology
Journal of Clinical Oncology, 30(5), 567-570. AMER SOC CLINICAL ONCOLOGY
Schneiders, F L, de Bruin, R C G, van den Eertwegh, A J M, Scheper, R J, Leemans, C R, Brakenhoff, R H, Langendijk, J A, Verheul, H M W, de Gruijl, T D, Molling, J W & van der Vliet, J J 2012, ' Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up ', Journal of Clinical Oncology, vol. 30, no. 5, pp. 567-570 . https://doi.org/10.1200/JCO.2011.38.8819
Journal of Clinical Oncology, 30(5), 567-570. AMER SOC CLINICAL ONCOLOGY
Schneiders, F L, de Bruin, R C G, van den Eertwegh, A J M, Scheper, R J, Leemans, C R, Brakenhoff, R H, Langendijk, J A, Verheul, H M W, de Gruijl, T D, Molling, J W & van der Vliet, J J 2012, ' Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up ', Journal of Clinical Oncology, vol. 30, no. 5, pp. 567-570 . https://doi.org/10.1200/JCO.2011.38.8819
Autor:
Walter Paulus, Hans W.M. Niessen, Alice Muller, Victor W.M. van Hinsbergh, Arthur J. Verhoeven, C. Erik Hack, Paul A.J. Krijnen, Johan W. Molling, Jessica A. Sipkens, Geerten P. van Nieuw Amerongen, Jan A. Rauwerda, Coen D.A. Stehouwer
Publikováno v:
Journal of Molecular and Cellular Cardiology, 49(5), 781-790. Academic Press Inc.
Journal of molecular and cellular cardiology, 49(5), 781-790. Academic Press Inc.
Krijnen, P A J, Sipkens, J A, Molling, J W, Rauwerda, J A, Stehouwer, C D A, Muller, A, Paulus, W J, van Nieuw Amerongen, G P, Hack, C E, Verhoeven, A J, van Hinsbergh, V W M & Niessen, H W M 2010, ' Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase ', Journal of Molecular and Cellular Cardiology, vol. 49, no. 5, pp. 781-790 . https://doi.org/10.1016/j.yjmcc.2010.07.017
Journal of Molecular and Cellular Cardiology, 49(5), 781-790. ELSEVIER SCI LTD
Journal of molecular and cellular cardiology, 49(5), 781-790. Academic Press Inc.
Krijnen, P A J, Sipkens, J A, Molling, J W, Rauwerda, J A, Stehouwer, C D A, Muller, A, Paulus, W J, van Nieuw Amerongen, G P, Hack, C E, Verhoeven, A J, van Hinsbergh, V W M & Niessen, H W M 2010, ' Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase ', Journal of Molecular and Cellular Cardiology, vol. 49, no. 5, pp. 781-790 . https://doi.org/10.1016/j.yjmcc.2010.07.017
Journal of Molecular and Cellular Cardiology, 49(5), 781-790. ELSEVIER SCI LTD
Subsequent to myocardial infarction, cardiomyocytes within the infarcted areas and border zones expose phosphatidylserine (PS) in the outer plasma membrane leaflet (flip-flop). We showed earlier that in addition to apoptosis, this flip-flop can be re
Autor:
Jacqueline A.E. Langius, Johan W. Molling, C. René Leemans, Johannes A. Langendijk, Rik J. Scheper, Hetty J. Bontkes, Alfons J.M. van den Eertwegh, Hans van Vliet, B. Mary E. von Blomberg
Publikováno v:
Journal of Clinical Oncology, 25, 7, pp. 862-8
Journal of Clinical Oncology, 25(7), 862-868. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 25, 862-8
Molling, J W, Langius, J A E, Langendijk, J A, Leemans, C R, Bontkes, H J, van der Vliet, H J J, von Blomberg, B M E, Scheper, R J & van den Eertwegh, A J M 2007, ' Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma ', Journal of Clinical Oncology, vol. 25, no. 7, pp. 862-8 . https://doi.org/10.1200/JCO.2006.08.5787
Journal of Clinical Oncology, 25(7), 862-8. American Society of Clinical Oncology
Journal of Clinical Oncology, 25(7), 862-868. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 25, 862-8
Molling, J W, Langius, J A E, Langendijk, J A, Leemans, C R, Bontkes, H J, van der Vliet, H J J, von Blomberg, B M E, Scheper, R J & van den Eertwegh, A J M 2007, ' Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma ', Journal of Clinical Oncology, vol. 25, no. 7, pp. 862-8 . https://doi.org/10.1200/JCO.2006.08.5787
Journal of Clinical Oncology, 25(7), 862-8. American Society of Clinical Oncology
Purpose Evading antitumor immune responses is an important aspect of the pathogenesis of head and neck squamous cell carcinoma (HNSCC). Invariant CD1d-restricted natural killer T (iNKT) cells play an allegedly pivotal role in such responses via trans
Autor:
Wendy Kölgen, Anita G.M. Stam, Johan W. Molling, Chris J. J. Mulder, Alfons J.M. van den Eertwegh, Tanja D. de Gruijl, Rik J. Scheper, Nobusuke Nishi, Carin J.M. van Nieuwkerk, Hans van Vliet, Harry L.A. Janssen, B. Mary E. von Blomberg
Publikováno v:
Clinical Immunology, 114(2), 183-189. Academic Press Inc.
van der Vliet, H J J, Molling, J W, von Blomberg, B M E, Kölgen, W, Stam, A G, de Gruijl, T D, Mulder, C J, Janssen, H L A, Nishi, N, van den Eertwegh, A J M, Scheper, R J & van Nieuwkerk, C J M 2005, ' Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients ', Clinical Immunology, vol. 114, no. 2, pp. 183-189 . https://doi.org/10.1016/j.clim.2004.10.001
Clinical Immunology, 114(2), 183-189. Academic Press
van der Vliet, H J J, Molling, J W, von Blomberg, B M E, Kölgen, W, Stam, A G, de Gruijl, T D, Mulder, C J, Janssen, H L A, Nishi, N, van den Eertwegh, A J M, Scheper, R J & van Nieuwkerk, C J M 2005, ' Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients ', Clinical Immunology, vol. 114, no. 2, pp. 183-189 . https://doi.org/10.1016/j.clim.2004.10.001
Clinical Immunology, 114(2), 183-189. Academic Press
CD1d-restricted natural killer T (NKT) cells are involved in the regulation of various immune responses, and have been shown to inhibit viral replication in animal hepatitis models when activated by the glycolipid alpha-galactosylceramide (alpha-GalC
Autor:
Carolien H. Smorenburg, Wendy Kölgen, Barbara G. Molenkamp, Rik J. Scheper, Alfons J.M. van den Eertwegh, Hans van Vliet, C. René Leemans, B. Mary E. von Blomberg, Hinke M. Kruizenga, Johan W. Molling, Martijn F Boomsma, Johannes A. Langendijk
Publikováno v:
International Journal of Cancer, 116(1), 87-93. Wiley-Liss Inc.
International Journal of Cancer, 116(1), 87-93. Wiley
Molling, J W, Kölgen, W, van der Vliet, H J J, Boomsma, M F, Kruizenga, H, Smorenburg, C H, Molenkamp, B G, Langendijk, J A, Leemans, C R, von Blomberg, B M E, Scheper, R J & van den Eertwegh, A J M 2005, ' Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load ', International Journal of Cancer, vol. 116, no. 1, pp. 87-93 . https://doi.org/10.1002/ijc.20998
International Journal of Cancer, 116(1), 87-93. Wiley
Molling, J W, Kölgen, W, van der Vliet, H J J, Boomsma, M F, Kruizenga, H, Smorenburg, C H, Molenkamp, B G, Langendijk, J A, Leemans, C R, von Blomberg, B M E, Scheper, R J & van den Eertwegh, A J M 2005, ' Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load ', International Journal of Cancer, vol. 116, no. 1, pp. 87-93 . https://doi.org/10.1002/ijc.20998
Natural killer T (NKT) cells are CDld-restricted lvmphoid cells and are characterized by an invariant T-cell receptor, which in humans consists of a V alpha 24 chain paired with a V beta 11 chain. These cells are known for their rapid production of l
Autor:
Hans van Vliet, Alfons J.M. van den Eertwegh, Nobusuke Nishi, Johan W. Molling, Giuseppe Giaccone, B. Mary E. von Blomberg, Wendy Kölgen, Rik J. Scheper, Herbert M. Pinedo
Publikováno v:
van der Vliet, H J J, Molling, J W, von Blomberg, B M E, Nishi, N, Kölgen, W, van den Eertwegh, A J M, Pinedo, H M, Giaccone, G & Scheper, R J 2004, ' The immunoregulatory role of CD1d-restricted natural killer T cells in disease ', Clinical Immunology, vol. 112, no. 1, pp. 8-23 . https://doi.org/10.1016/j.clim.2004.03.003
Natural killer T (NKT) cells constitute a T cell subpopulation that shares several characteristics with NK cells. NKT cells are characterized by a narrow T cell antigen receptor (TCR) repertoire, recognize glycolipid antigen in the context of the mon
Autor:
B. Mary E. von Blomberg, Hetty J. Bontkes, Johan W. Molling, Alfons J.M. van den Eertwegh, Rik J. Scheper, Jan Willem de Groot, Maria Moreno, Hans van Vliet
Publikováno v:
Molling, J W, Moreno, M, Groot, J, van der Vliet, J J, von Blomberg, B M E, van den Eertwegh, A J M, Scheper, R J & Bontkes, H J 2008, ' Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases ', Immunology Letters, vol. 118, no. 1, pp. 36-43 . https://doi.org/10.1016/j.imlet.2008.02.007
Immunology Letters, 118, 36-43
Immunology Letters, 118, 1, pp. 36-43
Immunology Letters, 118(1), 36-43. Elsevier
Immunology Letters, 118, 36-43
Immunology Letters, 118, 1, pp. 36-43
Immunology Letters, 118(1), 36-43. Elsevier
Contains fulltext : 69635.pdf (Publisher’s version ) (Closed access) In pre-clinical models, CD1d restricted invariant Natural Killer T (iNKT) cells play a pivotal role in natural anti-tumor immune responses, mainly by trans-activating cells of bot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ecd68b4d5a0d0799a9a8c19c98e6a5
https://research.vumc.nl/en/publications/1eacbc5e-3a41-4032-8c3e-924b63341ee6
https://research.vumc.nl/en/publications/1eacbc5e-3a41-4032-8c3e-924b63341ee6
Autor:
Duco Kramer, Anneke W. Reurs, Johan W. Molling, Rik J. Scheper, René H.M. Verheijen, B. Mary E. von Blomberg, Hetty J. Bontkes, Silvia von Mensdorff-Pouilly, María Moreno, Alfons J.M. van den Eertwegh, Erik Hooijberg
Publikováno v:
Journal of Immunology, 181, 4, pp. 2446-54
Journal of Immunology, 181(4), 2446-2454. American Association of Immunologists
Journal of Immunology, 181, 2446-54
Moreno, M, Molling, J W, von Mensdorff-Pouilly, S, Verheijen, R H M, Hooijberg, E, Kramer, D, Reurs, A W, van den Eertwegh, A J M, von Blomberg, B M E, Scheper, R J & Bontkes, H J 2008, ' IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses ', Journal of Immunology, vol. 181, no. 4, pp. 2446-2454 . https://doi.org/10.4049/jimmunol.181.4.2446
Journal of Immunology, 181(4), 2446-2454. American Association of Immunologists
Journal of Immunology, 181, 2446-54
Moreno, M, Molling, J W, von Mensdorff-Pouilly, S, Verheijen, R H M, Hooijberg, E, Kramer, D, Reurs, A W, van den Eertwegh, A J M, von Blomberg, B M E, Scheper, R J & Bontkes, H J 2008, ' IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses ', Journal of Immunology, vol. 181, no. 4, pp. 2446-2454 . https://doi.org/10.4049/jimmunol.181.4.2446
Contains fulltext : 69909.pdf (Publisher’s version ) (Closed access) CD1d-restricted invariant NKT (iNKT) cells can enhance immunity to cancer or prevent autoimmunity, depending on the cytokine profile secreted. Antitumor effects of the iNKT cell l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de17da8fd229a7aba843ad9aab8c42b9
https://hdl.handle.net/2066/69909
https://hdl.handle.net/2066/69909
Autor:
María Moreno, Hans J. van der Vliet, Johan W. Molling, Alfons J.M. van den Eertwegh, Rik J. Scheper, H. J. Bontkes, B. Mary E. von Blomberg
Publikováno v:
Clinical Immunology, 129, 182-94
Clinical Immunology, 129(2), 182-194. Academic Press Inc.
Clinical Immunology, 129, 2, pp. 182-94
Molling, J W, Moreno, M, van der Vliet, J J, van den Eertwegh, A J M, Scheper, R J, von Blomberg, B M E & Bontkes, H J 2008, ' Invariant natural killer T cells and immunotherapy of cancer ', Clinical Immunology, vol. 129, no. 2, pp. 182-194 . https://doi.org/10.1016/j.clim.2008.07.025
Clinical Immunology, 129(2), 182-194. Academic Press Inc.
Clinical Immunology, 129, 2, pp. 182-94
Molling, J W, Moreno, M, van der Vliet, J J, van den Eertwegh, A J M, Scheper, R J, von Blomberg, B M E & Bontkes, H J 2008, ' Invariant natural killer T cells and immunotherapy of cancer ', Clinical Immunology, vol. 129, no. 2, pp. 182-194 . https://doi.org/10.1016/j.clim.2008.07.025
Contains fulltext : 69606.pdf (Publisher’s version ) (Closed access) Invariant CD1d restricted natural killer T (iNKT) cells are regulatory cells that express a canonical TCR-Valpha-chain (Valpha24.Jalpha18 in humans and Valpha14.Jalpha18 in mice)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f81b5f0751bab67f2c4dd6005445d18
http://hdl.handle.net/2066/69606
http://hdl.handle.net/2066/69606
Autor:
Erik Bennink, Roger P.M. Sutmuller, Johan W. Molling, Gosse J. Adema, Stefan Nierkens, Liza W.J. Toonen, Oliver Grauer
Publikováno v:
Journal of Immunology, 181, 6720-9
Journal of Immunology, 181, 10, pp. 6720-9
Journal of Immunology, 181, 10, pp. 6720-9
Contains fulltext : 70899.pdf (Publisher’s version ) (Closed access) Local TLR stimulation is an attractive approach to induce antitumor immunity. In this study, we compared various TLR ligands for their ability to affect murine GL261 cells in vitr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa51b80ed73764786bb64be99340f058
https://doi.org/10.4049/jimmunol.181.10.6720
https://doi.org/10.4049/jimmunol.181.10.6720